MSB 12.1% 55.5¢ mesoblast limited

You are right. I stand corrected. Just checked the FDA guidance...

  1. 162 Posts.
    lightbulb Created with Sketch. 51
    You are right. I stand corrected. Just checked the FDA guidance on the subject.

    They also say:
    "The execution of an interim analysis should be a completely confidential process... All staff involved in the conduct of the trial should remain blind to the results of such analyses... This principle may be applied to all investigator staff and to staff employed by the sponsor except for those who are directly involved in the execution of the interim analysis. Investigators should be informed only about the decision to continue or discontinue the trial, or to implement modifications to trial procedures".

    It further says:
    "When a sponsor assumes the role of monitoring efficacy or safety comparisons and therefore has access to unblinded comparative information, particular care should be taken... to manage and limit appropriately the sharing of information."

    I guess if Teva took a lead in this process, they get to take a look.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
55.5¢
Change
0.060(12.1%)
Mkt cap ! $633.0M
Open High Low Value Volume
50.0¢ 59.0¢ 48.5¢ $16.88M 30.80M

Buyers (Bids)

No. Vol. Price($)
4 62700 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 40000 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
55.5¢
  Change
0.060 ( 15.7 %)
Open High Low Volume
50.5¢ 59.0¢ 48.5¢ 11524458
Last updated 16.02pm 29/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.